Home » Stocks » Harmony Biosciences

Harmony Biosciences Holdings, Inc. (HRMY)

Stock Price: $30.96 USD -2.64 (-7.86%)
Updated Sep 21, 2020 4:00 PM EDT - Market closed
After-hours: $30.99 +0.03 (0.10%) Sep 21, 4:07 PM

Stock Price Chart

Key Info

Market Cap 1.97B
Revenue (ttm) 63.84M
Net Income (ttm) -106.99M
Shares Out 63.68M
EPS (ttm) -2.33
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Sep 21, 2020
Last Price $30.96
Previous Close $33.60
Change ($) -2.64
Change (%) -7.86%
Day's Open 33.00
Day's Range 30.87 - 34.24
Day's Volume 260,020
52-Week Range 30.87 - 47.37

More Stats

Market Cap 1.97B
Enterprise Value 2.09B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 63.68M
Float 20.85M
EPS (basic) n/a
EPS (diluted) -2.33
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 347,261
Short Ratio 0.51
Short % of Float 1.98%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 30.88
PB Ratio n/a
Revenue 63.84M
Operating Income n/a
Net Income -106.99M
Free Cash Flow n/a
Net Cash -116.24M
Net Cash / Share -1.83
Gross Margin 6.92%
Operating Margin n/a
Profit Margin -229.45%
FCF Margin n/a
ROA n/a
ROE n/a
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 2
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(66.89% upside)
Current: $30.96
Target: 51.67
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Gross Profit4.42-
Operating Income-146-41.44
Net Income-152-39.90
Shares Outstanding7.788.86
Earnings Per Share-24.07-7.91
Operating Cash Flow-75.44-38.80
Capital Expenditures-0.15-1.34
Free Cash Flow-75.59-40.14
Cash & Equivalents24.4683.52
Total Debt97.95-
Net Cash / Debt-73.4983.52
Book Value-423-243
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Harmony Biosciences Holdings, Inc.
Country United States
Employees 150
CEO John C.s Jacobs

Stock Information

Ticker Symbol HRMY
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: HRMY
IPO Date August 19, 2020


Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.